Optivia Biotechnology Inc.
Optivia is capital-efficient nearly-profitable leader in a fast growing market looking for global and business expansion
Optivia delivers capital-efficient innovation in transporter biology and therapeutic development. Its highly differentiated transporter assay services help clients meet regulatory requirement and improve drug response and toxicity. Having become a global leader in transporter assays, Optivia is building an one-stop shop of preclinical research services, by leveraging global assets and capabilities using a novel capital-efficient CRO 2.0 model.